HOPA Publishes Investigational Drug Service Best Practice Standards
We are pleased to announce the HOPA Standards Committee has completed the HOPA Investigational Drug Service Best Practice Standards, the first of its kind that provides the best practice standards and guidance for pharmacists and institutions that conduct clinical trials. The HOPA Investigational Drug Service Best Practice Standards emphasizes the critical role of the pharmacist in the investigational drug service from protocol concept to close-out. This document provides a foundation for pharmacy to be involved very early in protocol development and review, to ensure that the trial meets institutional medication guidelines, is executed efficiently, and adheres to all regulations and standards. In addition, the guidelines provide an outline for the role of the pharmacy technician which is unique to this document. These guidelines address various best practices for pharmacy operations and provide ancillary information about the different mechanisms for obtaining investigational drugs for a single patient, and provide a concise summary of and reference source for the procedures for obtaining investigational drugs on a “compassionate” basis. This best practice guideline should be used in conjunction with other applicable state and federal guidelines.
HOPA wishes to thank the following members for their valuable contributions:
Editor
Barry Goldspiel, PharmD BCPS BCOP
Lead Authors
Sapna Amin, PharmD BCOP
Joyce Lee, PharmD BCOP BCPS
Authors
Jorge Avila, PharmD BCOP
Matthew Boron, RPh
Stefanie Conley, PharmD RPh
Robert Enos, RPh MBA
Kathy Galus, PharmD BCOP
Theresa Mays, PharmD BS BCOP FASHP
Gopal Patil, PhD MBA RPh
Jennifer Thompson, PharmD BCOP CCRP
Peer Reviewers
Linda Bressler, PharmD BS
Michael Kane, RPh BCOP
Jennifer LaFollette, PharmD BCOP
Susan Rogers, RPh
You can access the HOPA Investigational Drug Service Best Practice Standards on HOPA’s website.